Park National Corp’s Gilead Sciences GILD Stock Holding History

Park National Corp’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-140	Closed	-$19.5K	–	373
2026 Q1	$19.5K	Buy	+140	New	+$19.6K	﹤0.01%	363
2025 Q1	–	Sell	-4,991	Closed	-$461K	–	297
2024 Q4	$461K	Buy	4,991 +45	+0.9%	+$4.05K	0.02%	218
2024 Q3	$415K	Sell	4,946 -442	-8%	-$33.7K	0.01%	222
2024 Q2	$370K	Sell	5,388 -425	-7%	-$28.4K	0.01%	229
2024 Q1	$426K	Buy	5,813 +2,071	+55%	+$159K	0.02%	214
2023 Q4	$303K	Sell	3,742 -350	-9%	-$27.2K	0.01%	241
2023 Q3	$307K	Buy	4,092 +752	+23%	+$57.8K	0.01%	235
2023 Q2	$257K	Hold	3,340	–	–	0.01%	244
2023 Q1	$277K	Sell	3,340 -68	-2%	-$5.63K	0.01%	230
2022 Q4	$293K	Sell	3,408 -100	-3%	-$7.92K	0.01%	228
2022 Q3	$216K	Hold	3,508	–	–	0.01%	248
2022 Q2	$216K	Sell	3,508 -83	-2%	-$5.14K	0.01%	254
2022 Q1	$214K	Sell	3,591 -483	-12%	-$30.9K	0.01%	268
2021 Q4	$296K	Sell	4,074 -200	-5%	-$13.8K	0.01%	246
2021 Q3	$299K	Hold	4,274	–	–	0.01%	245
2021 Q2	$295K	Sell	4,274 -150	-3%	-$10K	0.01%	244
2021 Q1	$286K	Sell	4,424 -126	-3%	-$8.13K	0.01%	259
2020 Q4	$265K	Sell	4,550 -977	-18%	-$59K	0.01%	259
2020 Q3	$349K	Sell	5,527 -54	-1%	-$3.75K	0.02%	218
2020 Q2	$429K	Sell	5,581 -46	-0.8%	-$3.52K	0.02%	200
2020 Q1	$421K	Buy	5,627 +100	+2%	+$6.91K	0.03%	190
2019 Q4	$359K	Hold	5,527	–	–	0.02%	238
2019 Q3	$350K	Sell	5,527 -975	-15%	-$63.7K	0.02%	237
2019 Q2	$439K	Sell	6,502 -605	-9%	-$39.8K	0.02%	211
2019 Q1	$462K	Sell	7,107 -281	-4%	-$18.7K	0.03%	199
2018 Q4	$463K	Buy	7,388 +541	+8%	+$37.8K	0.03%	199
2018 Q3	$529K	Sell	6,847 -60	-0.9%	-$4.53K	0.03%	204
2018 Q2	$490K	Sell	6,907 -755	-10%	-$53.3K	0.03%	210
2018 Q1	$577K	Buy	7,662 +17	+0.2%	+$1.35K	0.03%	190
2017 Q4	$548K	Sell	7,645 -181	-2%	-$13.7K	0.03%	197
2017 Q3	$634K	Sell	7,826 -145	-2%	-$11.1K	0.04%	185
2017 Q2	$565K	Buy	7,971 +120	+2%	+$7.99K	0.03%	187
2017 Q1	$534K	Buy	7,851 +1,550	+25%	+$109K	0.03%	196
2016 Q4	$451K	Buy	6,301 +553	+10%	+$41.1K	0.03%	204
2016 Q3	$454K	Sell	5,748 -74	-1%	-$6.01K	0.03%	206
2016 Q2	$486K	Buy	5,822 +513	+10%	+$45.5K	0.03%	200
2016 Q1	$487K	Buy	5,309 +587	+12%	+$52.9K	0.03%	193
2015 Q4	$478K	Buy	4,722 +1,118	+31%	+$116K	0.03%	193
2015 Q3	$354K	Buy	3,604 +680	+23%	+$75.5K	0.03%	216
2015 Q2	$342K	Sell	2,924 -33	-1%	-$3.61K	0.02%	240
2015 Q1	$290K	Buy	2,957 +219	+8%	+$22.2K	0.02%	258
2014 Q4	$258K	Buy	2,738 +80	+3%	+$8.27K	0.02%	281
2014 Q3	$283K	Buy	+2,658	New	+$260K	0.02%	257

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Park National Corp's GILD Position: Q2 2026 in Review

Park National Corp sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 140 shares — an estimated $19.5K sold.

Park National Corp first reported a position in GILD in Q3 2014 and held it in 43 quarters. The position peaked at $634K in Q3 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Park National Corp reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Park National Corp sold 140 Gilead Sciences shares in Q2 2026, an estimated $19.5K.
Park National Corp first reported a position in Gilead Sciences in Q3 2014 and held it in 43 quarters.
Park National Corp's Gilead Sciences position peaked at $634K in Q3 2017.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.